WallStreetZenWallStreetZen

NYSEMKT: CITR
Citrotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CITR

Based on 1 analyst offering 12 month price targets for Citrotech Inc

Min Forecast
$16.00+227.2%
Avg Forecast
$16.00+227.2%
Max Forecast
$16.00+227.2%

Should I buy or sell CITR stock?

Based on 1 analyst offering ratings for Citrotech Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CITR stock forecasts and price targets.

CITR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-11

1 of 1

Forecast return on equity

Is CITR forecast to generate an efficient return?

Company
-142.94%
Industry
28.29%
Market
135.89%
CITR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CITR forecast to generate an efficient return on assets?

Company
-128.36%
Industry
9.01%
CITR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CITR earnings per share forecast

What is CITR's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.90
Avg 2 year Forecast
-$0.57

CITR revenue forecast

What is CITR's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$22.8M+1,588.71%
Avg 2 year Forecast
$22.8M+1,592.48%
CITR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CITR revenue growth forecast

How is CITR forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
1,588.71%
Industry
4.95%
Market
18.69%
CITR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CITR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CITR vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
CITR$4.89$16.00+227.20%Buy
FSI$5.80N/AN/A
NTIC$7.72N/AN/A
FEAM$1.76$3.50+98.86%Buy
LOOP$0.48N/AN/A
View Top Specialty Chemical Stocks

Citrotech Stock Forecast FAQ

Is Citrotech Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: CITR) stock is to Buy CITR stock.

Out of 1 analyst, 0 (0%) are recommending CITR as a Strong Buy, 1 (100%) are recommending CITR as a Buy, 0 (0%) are recommending CITR as a Hold, 0 (0%) are recommending CITR as a Sell, and 0 (0%) are recommending CITR as a Strong Sell.

If you're new to stock investing, here's how to buy Citrotech stock.

What is CITR's earnings growth forecast for 2026-2027?

(NYSEMKT: CITR) Citrotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 112.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,224.85%.

Citrotech's earnings in 2026 is -$24,143,338.On average, 3 Wall Street analysts forecast CITR's earnings for 2026 to be -$20,243,998, with the lowest CITR earnings forecast at -$19,450,116, and the highest CITR earnings forecast at -$20,839,410.

In 2027, CITR is forecast to generate -$12,882,544 in earnings, with the lowest earnings forecast at -$12,377,347 and the highest earnings forecast at -$13,261,443.

What is CITR's revenue growth forecast for 2026-2027?

(NYSEMKT: CITR) Citrotech's forecast annual revenue growth rate of 1,588.71% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.95%, and it is also forecast to beat the US market's average forecast revenue growth rate of 18.69%.

Citrotech's revenue in 2026 is $1,349,968.On average, 3 Wall Street analysts forecast CITR's revenue for 2026 to be $514,151,547, with the lowest CITR revenue forecast at $493,988,741, and the highest CITR revenue forecast at $529,284,928.

In 2027, CITR is forecast to generate $515,301,774 in revenue, with the lowest revenue forecast at $495,093,861 and the highest revenue forecast at $530,457,708.

What is CITR's forecast return on assets (ROA) for 2026-2027?

(NYSEMKT: CITR) forecast ROA is -128.36%, which is lower than the forecast US Specialty Chemicals industry average of 9.01%.

What is CITR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CITR price target, the average CITR price target is $16.00, with the highest CITR stock price forecast at $16.00 and the lowest CITR stock price forecast at $16.00.

The Wall Street analyst predicted that Citrotech's share price could reach $16.00 by Jun 11, 2027. The average Citrotech stock price prediction forecasts a potential upside of 227.2% from the current CITR share price of $4.89.

What is CITR's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: CITR) Citrotech's current Earnings Per Share (EPS) is -$1.18. On average, analysts forecast that CITR's EPS will be -$0.90 for 2026, with the lowest EPS forecast at -$0.86, and the highest EPS forecast at -$0.92. In 2027, CITR's EPS is forecast to hit -$0.57 (min: -$0.55, max: -$0.59).

What is CITR's forecast return on equity (ROE) for 2026-2027?

(NYSEMKT: CITR) forecast ROE is -142.94%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.